Markel Group's 2023 letter to business partners
- Written by
- Thomas S. Gayner
- Organisation
- Markel Group
- Filed
- 6 Mar 2024
- Sector
- Specialty insurance and holding company
Read the original at sec.gov (opens in a new tab)
This is the view as filed on 6 Mar 2024, not a statement of what the author thinks today.
About this letter
Thomas S. Gayner, chief executive officer of Markel Group, wrote this letter to the company's business partners at the front of its 2023 annual report. He warns at the outset that the 2023 letter will be longer than usual, borrowing Dickens to call the year the best of times and the worst of times.
The letter is framed by the Markel Style, the creed the company wrote in 1986, and by its definition of success as building one of the world's great companies. It reports on each of what Markel calls its three engines: insurance, where the company fell short of its goals; Markel Ventures, the majority-owned non-insurance businesses it began acquiring in 2005; and investments. It closes with the four basic choices for allocating the capital the group generates and with how management estimates intrinsic value per share.
Why read it
It explains, in a chief executive's own words, a simple two-part method for estimating intrinsic value per share and how that estimate guides decisions to repurchase or issue shares.
What to notice
- 1
The Orange and Blue method: Orange is investments and cash less debt, per share; Blue is normalised operating earnings after interest and tax, times a conservative and consistent multiple, per share. Added together they give Markel's sense of intrinsic value.
Continue the investment thesis
See the 3 remaining takeaways on what this investor is arguing and why, and every analysis across the Letters & Theses library.
Checking what you can open…
“We would wither away if we didn’t embrace change.”
Companies discussed
- Markel Group Inc.
Topics
- capital allocation
- valuation
- mistakes
- risk
- long term ownership
- culture
L3VLUP does not host this document. It belongs to Markel Group and is a public SEC filing; the notes above are L3VLUP’s reading of it.
More from Markel Group
- Markel Group's 2025 letter to shareholders · 26 Feb 2026
The same argument, elsewhere
- Berkshire Hathaway's 2011 letter to shareholders · Berkshire Hathaway
- Berkshire Hathaway's 2005 letter to shareholders · Berkshire Hathaway
- Starboard's February 2019 letter to Bristol-Myers Squibb shareholders on the Celgene deal · Starboard Value
- JANA Partners' 2017 letter to EQT stockholders opposing the Rice acquisition · JANA Partners